Report: U.S. Alcohol Dependence and Abuse Pharmaceuticals Market - Therapeutic Overview and Patient Outlook

U.S. Alcohol Dependence and Abuse Pharmaceuticals Market - Therapeutic Overview and Patient Outlook

Published by

Frost & Sullivan

Published

2008/01

Content info

Product code

FS59680

Price

From US $ 6000

PDF by E-Mail

Approx. 1-2 business days

Hard Copy/CD-ROM

Approx. 3-4 business days

If you need expedited delivery, please call us.

Abstract

This research service covers the U.S. alcohol dependence and abuse pharmaceuticals market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product as follows: Antabuse, Campral, ReVia, and Vivitrol. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.

Related Report

Alzheimer disease - new drugs, markets and companies Commercial Insight: Antidepressants - Novel mechanism offers hope in depressed market Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion World Market for Addiction Disorders, 2009 - 2016, The Future Therapies for Substance Dependence and Impulse Control Special Report - The Autism Spectrum Disorders Market: Substantial Opportunity and Unique Challenges